{"transactions":[{"id":3468154,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":156168,"kind":"person","name":"Kerr Giles Francis Bertram","position":1,"cik":"0001689112","reported_name":"Kerr Giles Francis Bertram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2019-07-03T17:00:49.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":124000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.48 based on an exchange rate of $U.S. 1.2638 to GBP1.00.  The actual exercise price will be the pounds sterling amount."}],"balance_after":124000,"derivative":{"exercise_price":0.61,"exercise_date":"2020-07-02","expiration_date":"2029-07-02","underlying":"Ordinary Shares","underlying_shares":124000},"source":{"system":"sec-edgar","filing":"0001104659-19-039323","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689112/000110465919039323/a4.xml","form_type":"4"}},{"id":3883210,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":156168,"kind":"person","name":"Kerr Giles Francis Bertram","position":1,"cik":"0001689112","reported_name":"Kerr Giles Francis Bertram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2018-06-26T17:00:53.000Z","date":"2018-06-22","kind":"grant","acquired":true,"shares":124000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP1.65 based on an exchange rate of $U.S. 1.3250 to GBP1.00.  The actual exercise price will be the pounds sterling amount."}],"balance_after":124000,"derivative":{"exercise_price":2.18,"exercise_date":"2019-06-22","expiration_date":"2028-06-22","underlying":"Ordinary Shares","underlying_shares":124000},"source":{"system":"sec-edgar","filing":"0001104659-18-042321","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689112/000110465918042321/a4.xml","form_type":"4"}},{"id":4267674,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":156168,"kind":"person","name":"Kerr Giles Francis Bertram","position":1,"cik":"0001689112","reported_name":"Kerr Giles Francis Bertram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2017-07-03T17:01:39.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.58 based on the closing midpoint exchange rate for the U.S. dollar on the trading day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount."}],"balance_after":144000,"derivative":{"exercise_price":0.75,"exercise_date":"2018-07-03","expiration_date":"2027-07-03","underlying":"Ordinary Shares","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-17-043262","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689112/000110465917043262/a4.xml","form_type":"4"}},{"id":4537230,"issuer":{"id":9824,"kind":"organization","name":"Adaptimmune Therapeutics PLC"},"owners":[{"id":156168,"kind":"person","name":"Kerr Giles Francis Bertram","position":1,"cik":"0001689112","reported_name":"Kerr Giles Francis Bertram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Ordinary Shares","published_at":"2016-12-01T16:30:50.000Z","date":"2016-11-29","kind":"grant","acquired":true,"shares":288000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price was converted from GBP0.65 based on the closing midpoint exchange rate for the U.S. dollar on the trading day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable as to 72,000 Ordinary Shares on November 29, 2017 and will be exercisable as to the remainder in monthly installments of 9,000 Ordinary Shares on the twenty-ninth of each month from December 29, 2017 through November 29, 2019."}],"balance_after":288000,"derivative":{"exercise_price":0.81,"expiration_date":"2026-11-29","underlying":"Ordinary Shares","underlying_shares":288000},"source":{"system":"sec-edgar","filing":"0001104659-16-160132","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1689112/000110465916160132/a4.xml","form_type":"4"}}]}